DFCR board member Dr. Peter Grinspoon is interviewed by Spotlight PA regarding cannabis as a tool to fight opioid addition. Chris Braddock, a 37-year-old house painter from Washington County, said he struggled with opioid addiction for several years, going through […]
DFCR President Dr. Bryon Adinoff discusses the impact of prohibition, how cannabis legalization helps, and the medical community’s role. As an addiction psychiatrist, I am frustrated, angry, and even embarrassed by the refusal of physicians to acknowledge the failure of […]
New Jersey’s cannabis commission met Tuesday evening to hear public input on one of the flashpoint issues of marijuana legalization: how to package, label and advertise cannabis products without enticing children. Article excerpt: Dr. David Nathan, who founded the group […]
Doctors for Cannabis Regulation (DFCR) is pleased to announce Dr. Bryon Adinoff as the organization’s new president. He moves into the role previously held by outgoing Founder and now Past-President Dr. David Nathan, who remains as a member of the […]
Dr. Bryon Adinoff participated in a panel discussion for Texas Public Radio regarding recently enacted legislation for Texas’ medical cannabis program. Texas will expand access to medical cannabis for individuals with post-traumatic stress disorder and any form of cancer — […]
Doctors for Cannabis Regulation is proud to welcome Adriana Kertzer as its Board of Directors’ newest member! Adriana Kertzer is a Brazilian-American attorney, born and raised in São Paulo. Adriana has a J.D. from the Georgetown University Law Center, a […]
Doctors for Cannabis Regulation expert Dr. Mikhail Kogan provides testimony at the New Jersey Cannabis Regulatory Commission meeting held on June 1, 2021.
The American Medical Association (AMA) has become unmoored in history, seemingly unaware that both racism and the War on Drugs are no longer tolerated by society. A confluence of recent activities and events having to do with their stance on […]
DFCR expert Hugh Blumenfeld, MD, Ph.D. and DFCR Founder and board President David L. Nathan, MD make the case in an op-ed that, This year, Connecticut has the opportunity to join the 15 states that have replaced the failed policy […]
Article excerpt: In the retail cannabis industry, labeling and regulation go hand in hand. Within the United States, cannabis labeling regs are implemented state by state. Not surprisingly, each set of regulations is different from the next. A universal standard […]
Dr. Donald Lyman, a physician who authored Prop 64 to legalize cannabis in California, talks about his view on what Doctors for Cannabis Regulation represents.
Doctors for Cannabis Regulation marks its fifth year in operation with board members and experts talking about what it means to them for DFCR to hit this milestone.
Article excerpt: The AMA actively supports cannabis prohibition, a cornerstone of the drug war, even as it hypocritically condemns systemic racism for creating inequity and limiting access to health care among communities of color. The organization fails to appreciate or […]
Article excerpt: Q2 Clinic, the first international chain of Endocannabinology clinics, today announced the appointment of Dr. Peter Grinspoon, M.D. as Chief Medical Director (CMD). Dr. Grinspoon is a primary care physician and cannabis specialist at Massachusetts General Hospital and […]
DFCR spokesperson Dr. Hugh Blumenfeld speaks to the Connecticut General Assembly Judiciary Committee Hearing on February 26, 2021 in favor of legalizing cannabis.